By targeting the addictive design features of social media platforms, K.G.M. v. Meta marks a breakthrough in product liability law. Yet the case also reveals a neglected class dimension: the harms of addictive platform design fall most heavily on those with the fewest alternatives. In addition to regulating these harmful products, we must build a world in which children do not so desperately need them.

A decade ago, Martin Shkreli became the most hated man in America by raising the price of Daraprim – an antiparasitic essential for immunocompromised patients – from $17.50 to $750 per pill. Though Shkreli’s conduct was lambasted in the court of public opinion, the legal framework that allowed this 4,000 percent increase remains in place. And Daraprim? It still costs $750 a pill.